Biomarkers of Inflammation in Predicting the Outcomes of Heart Failure of Ischemic Etiology: the Results of Factor Analysis
Open Access
- 29 February 2024
- journal article
- research article
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 64 (2) , 18-26
Abstract
Aim . To study the prognostic significance of inflammatory biomarkers in patients with chronic heart failure (CHF) and stenotic multivessel coronary atherosclerosis, with determination of the biomarker separate set that reflects subclinical inflammation and is associated with the development of cardiovascular complications during prospective observation. Material and methods . A prospective observational study was conducted that included 80 patients with CHF and ischemic heart disease who were scheduled for coronary artery bypass grafting (CABG) during their current hospitalization. In addition to routine clinical laboratory tests, coagulation parameters were evaluated and the following inflammatory biomarkers were determined: neutrophil gelatinase-associated lipocalin (NGAL), growth/differentiation factor 15 (GDF-15), fibroblast growth factor 23 (FGF-23), transforming growth factor beta-1 (TGF-β1), and high-sensitivity C-reactive protein. Also, the calculated neutrophil-to-lymphocyte ratio (N LR) was included in the analysis. Follow-up duration was at least 12 months (median 16 [13, 22] months). Statistical analysis of the data was performed with the IBM SPSS Statistics 21 software. Results . The study presented results of a factor analysis of 10 inflammatory biomarkers in patients who were scheduled for CABG. One of the factors identified by the analysis included the levels of NGAL and GDF-15, N LR, and the level of fibrinogen in the blood in CHF patients with stenotic coronary atherosclerosis and was significantly associated with the death rate during prospective observation. Furthermore, this association remained significant even after adjustments for age, glomerular filtration rate, severity of heart and coronary insufficiency, and the presence of diabetes mellitus. Conclusion . In patients with CHF and stenotic coronary atherosclerosis, a set of inflammatory markers, including blood NGAL, GDF-15, N LR, and fibrinogen, can be combined into one factor reflecting subclinical inflammation. The value of this factor can be used to predict cardiovascular death in the long term after surgical myocardial revascularization.Keywords
This publication has 20 references indexed in Scilit:
- Predictive role of C-reactive protein in sudden death: a meta-analysis of prospective studiesJournal of International Medical Research, 2022
- Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseasesHeart Failure Reviews, 2021
- Targeting Smad-Mediated TGFß Pathway in Coronary Artery Bypass GraftJournal of Cardiovascular Pharmacology and Therapeutics, 2020
- Growth Differentiation Factor 15 as Mortality Predictor in Heart Failure Patients with Non-Reduced Ejection FractionESC Heart Failure, 2020
- Serum visfatin level is associated with complexity of coronary artery disease in patients with stable angina pectorisTherapeutic Advances in Cardiovascular Disease, 2019
- Role of Inflammation in Heart FailureCurrent Atherosclerosis Reports, 2017
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue PhysiologyCold Spring Harbor Perspectives in Biology, 2016
- From Risk Factors to Structural Heart Disease: The Role of InflammationHeart Failure Clinics, 2012
- The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection FractionEuropean Journal of Heart Failure, 2010
- Plasma Neutrophil Gelatinase-Associated Lipocalin and Acute Postoperative Kidney Injury in Adult Cardiac Surgical PatientsAnesthesia & Analgesia, 2010